Omeros is a Seattle-based biopharmaceutical company committed to discovering, developing, and commercializing small-molecule and protein therapeutics for large-market as well as orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system
Seattle, US
Size (employees)
162 (est)
Omeros is headquartered in Seattle, US

Key People at Omeros

Gregory A. Demopulos

Gregory A. Demopulos

Chairman and Chief Executive Officer
Wayne Wager

Wayne Wager

Timothy M. Duffy

Timothy M. Duffy

Vice President, Business Development

Omeros Office Locations

Omeros has office in Seattle
Seattle, US

Omeros Metrics

Omeros Summary

Market capitalization

$490.1 m

Closing share price

Omeros's current market capitalization is $490.1 m.

Omeros Financials

Omeros's revenue is $1.6 m in FY, 2013 which is a 196.8% increase from the previous period.
FY, 2013FY, 2014FY, 2015Y, 2016


$1.6 m$539 k$13.5 m$41.6 m

Revenue growth, %


Cost of goods sold

$1 m$1.4 m

Operating expense total

$52.1 m$70.5 m$84.7 m$95.9 m


($50.5 m)($70 m)($71.2 m)($54.3 m)

Interest expense

($2.4 m)($3.5 m)($3.6 m)($7.8 m)

Net Income

($39.8 m)($73.7 m)($75.1 m)($66.7 m)

Omeros Market Value History

Omeros Online Presence

Omeros News

Omeros Company Life

You may also be interested in